Clinical Trial Update: Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating a medication event monitoring system to improve adherence to Tecfidera in multiple sclerosis was terminated, with results posted on 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2017-05-16